Dutcher Bodies: Definition and Significance
Dutcher bodies are aggregates of immunoglobulins in the nucleus of plasma cells or lymphoplasmacytoid cells 1.
Characteristics of Dutcher Bodies
- Dutcher bodies are periodic acid-Schiff (PAS)-positive intranuclear pseudoinclusions 2
- They appear as eosinophilic inclusions within the nucleus of plasma cells or lymphoplasmacytoid cells
- They represent immunoglobulin accumulation within the nucleus, specifically:
Clinical Significance and Disease Associations
Dutcher bodies are primarily associated with:
Lymphoplasmacytic lymphomas:
Other B-cell neoplasms:
Rare occurrence in benign conditions:
- Occasionally found in chronic inflammatory conditions like chronic synovitis 2
- Not typically seen in reactive plasma cell proliferations
Diagnostic Value
- Dutcher bodies serve as an important morphological clue in the diagnosis of lymphoid neoplasms with plasmacytic differentiation
- Their presence can help distinguish MALT lymphoma from plasmacytoma in cytological specimens 4
- In lymphoplasmacytic lymphoma involving bone marrow, Dutcher bodies are a characteristic finding 1
- The intrafollicular distribution of cells containing Dutcher bodies may suggest follicular lymphoma 3
Differentiation from Other Inclusions
- Dutcher bodies should be distinguished from:
- Russell bodies (cytoplasmic immunoglobulin inclusions)
- Mott cells (plasma cells with multiple Russell bodies)
- Crystalline inclusions in the cytoplasm 6
Pathophysiology
Dutcher bodies represent abnormal trafficking of immunoglobulin that becomes stored within the nucleus rather than being properly secreted. They are not limited to a specific B-cell lymphoma type but can occur in any immunoglobulin-producing B-cell neoplasm 5.
In summary, Dutcher bodies are nuclear immunoglobulin inclusions most commonly associated with lymphoplasmacytic lymphoma and other B-cell neoplasms with plasmacytic differentiation. Their identification through appropriate staining techniques provides valuable diagnostic information in the evaluation of lymphoproliferative disorders.